Article Summary
杨宇红 金延涛 高作书 傅钢 王海燕.血塞通在23G微创玻切手术治疗糖尿病性玻璃体积血的作用[J].现代生物医学进展英文版,2015,15(18):3496-3498.
血塞通在23G微创玻切手术治疗糖尿病性玻璃体积血的作用
Effect of Xuesaitong on 23G Minimally Invasive Vitrectomy Operation in theTreatment of Diabetic Vitreous Hemorrhage
  
DOI:
中文关键词: 糖尿病  玻璃体积血  注射用血塞通  23G 微创玻切手术
英文关键词: Diabetes mellitus  Vitreous hemorrhage  Xuesaitong  23G minimally invasive vitrectomy operation
基金项目:国家自然科学基金项目(81300770)
Author NameAffiliation
杨宇红 金延涛 高作书 傅钢 王海燕 陕西省第二人民医院 解放军323 医院第四军医大学西京医院 
Hits: 809
Download times: 925
中文摘要:
      目的:探讨注射用血塞通(冻干粉)在23G 微创玻切手术治疗糖尿病性玻璃体积血中的作用。方法:选取我院收治的2 型糖尿 病性玻璃体积血70 例,将其随机分为两组,均给予常规血糖控制及23G 微创玻切手术治疗,实验组于手术前给予注射用血塞通。 对比两组患者的手术时间、术后并发症的发生率以及视力恢复情况。结果:实验组的平均手术时间明显短于对照组,术后出血、房 性炎症、视网膜脱离、新生血管性青光眼并发症的发生率均明显低于对照组,差异有统计学意义(P<0.05);实验组视力恢复的总有 效率显著高于与对照组,差异有统计学意义(P<0.05)。结论:术前应用注射用血塞通能够明显提高23G微创玻切手术治疗糖尿病 性玻璃体积血的临床疗效,值得临床推广。
英文摘要:
      Objective:To explore the effect of Xuesaitong(lyophilized power)on 23G minimally invasive vitrectomy operation in the treatment of diabetic vitreous hemorrhage.Methods:70 cases of patients with type 2 diabetic vitreous hemorrhage who were treated in our hospital were selected and randomly divided into two groups. The patients in both groups were treated with normal blood glucose control and 23 g minimally invasive phaco surgical treatment. Besides, the patients in the experimental group were given blood flux injection before the surgery. Then the operation time, the incidence of postoperative complications and visual acuity of patients in the two groups were observed and compared.Results:The operation time of experimental group was significantly shorter than that of the control group, the incidence rates of hemorrhage, realinflammation, retinal detachment and neovascular glaucoma of experimental group were significantly lower than those of the control group, and the differences were statistically significant (P<0.05). The visual acuity of experimental group was better than that of the control group with statistically significant difference (P<0.05).Conclusion:Preoperative application of Xuesaitong injection could significantly improve the curative effect of 23G minimally invasive vitrectomy operation in the treatment of diabetic vitreous hemorrhage, which was worthy of clinical promotion.
View Full Text   View/Add Comment  Download reader
Close